Recombinant CA 19-9 antibody

Catalog No. ABIN4949235

This Rabbit Monoclonal antibody specifically detects CA 19-9 in IHC (p). It exhibits reactivity toward Human.

Quick Overview for Recombinant CA 19-9 antibody (ABIN4949235)

Target: CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This CA 19-9 antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: CA19-9-1390R

Product Details anti-CA 19-9 Antibody

Purpose: Recombinant CA19-9 Antibody / Rabbit Monoclonal (azide and preservative free)

Purification: Protein A affinity

Immunogen: Purified human protein used as the immunogen for the recombinant CA19-9 antibody.

Isotype: IgG, kappa

Application Details

Application Notes: Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: 4 °C,-20 °C

Storage Comment: Store the recombinant CA19-9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Target Details for CA 19-9

Target: CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))

Alternative Name: CA19-9

Background: CA19-9, a carbohydrate epitope expressed on a high MW (>400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.